Malin misses out on $25.9m earnout as centrepiece drug key 2021 deal is scrapped
Company returned about €390 million to shareholders in the past five years as it sold down investments
Report or Request an Update
Let us know what is wrong or what information should be updated.
- Family
- News
- Platform
- Website
- Resource Type
- Newspaper
- Language
- English
- Country
- International
Resource Activity
0 views
Description
Company returned about €390 million to shareholders in the past five years as it sold down investments
Reviews
No approved reviews yet.